Immunovant, Inc. IMVT
33.30
(0.70)
(2.06%)
as of 25 Sep
- Market cap
- $7.1B
- P/E
- 0.0×
Follow IMVT
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
9.07 | 15.74 | 9.09 | 7.27 |
Net Debt/EBITDA |
3.96 | 8.70 | 5.66 | 4.98 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.81 | 0.83 | 0.64 | 0.81 | |
Capex/Depreciation |
0.00 | 0.00 | (0.08) | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.59) | (0.51) | (0.52) | (0.61) | |
Cash per Share |
3.01 | 5.48 | 4.95 | 3.88 | |
Shareholders Equity per Share |
2.99 | 5.43 | 4.67 | 3.58 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.99 | 5.43 | 4.67 | 3.58 | |
Free Cash Flow |
(102.51) | (92.32) | (95.07) | (124.40) | |
Working Capital |
510.29 | 976.68 | 844.40 | 734.08 | |
Capital Expenditures |
— | — | (0.01) | — | |
Net Current Asset Value |
510.29 | 976.68 | 844.40 | 734.08 | |
| Other line items | |||||
Quick Ratio |
8.28 | 15.03 | 8.65 | 6.82 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.59) | (0.51) | (0.52) | (0.61) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Receivables |
1.92 | 1.93 | 1.82 | 1.32 | |
Average Payables |
13.82 | 14.22 | 12.60 | 8.99 | |
Average Assets |
549.33 | 736.66 | 866.62 | 756.97 | |
Average Common Equity |
484.38 | 669.38 | 780.02 | 671.96 | |
Capex to Sales |
— | — | 0.00 | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates